Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Carl Herndon

Adult Reconstructive Orthopaedic Surgery New York, NY Medical Doctor

NPI 1619321809 CMS profile 9423977

622 W 168Th St Ph 11-1120, New York, NY 10032

Open in the dashboard

General payments

$68,048

116 records reported · program years 2021–2025

Research payments

$3,350

Paid to them · 1 record reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Carl Herndon of New York, NY is reported in the CMS Open Payments database as having received $68,048 across 116 general payments and $3,350 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,342 26
2024 General $40,381 39
2024 Research $3,350 1
2023 General $6,393 21
2022 General $1,105 20
2021 General $827 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Carl Herndon
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Carl Herndon were reported at $19,342. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Carl Herndon Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $0 $1,416 $292–$9,336 $163
2020 $0 $647 $141–$6,474 $114
2021 $827 $1,073 $211–$6,497 $132
2022 $1,105 $1,217 $236–$6,299 $149
2023 $6,393 $1,082 $246–$6,818 $160
2024 $40,381 $1,575 $323–$8,944 $164
2025 $19,342 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medical Device Business Services, Inc. $38,986 39 payments
  2. Solventum Corporation $10,909 5 payments
  3. Medtronic, Inc. $4,750 2 payments
  4. DePuy Synthes Products, Inc. $3,357 5 payments
  5. Synthes GmbH $2,982 5 payments
  6. Stryker Corporation $2,285 23 payments
  7. Zimmer Biomet Holdings, Inc. $1,396 11 payments
  8. DePuy Synthes Sales Inc. $1,208 11 payments
  9. KCI USA, Inc $1,078 5 payments
  10. Smith+Nephew, Inc. $957 8 payments
  11. Other $140 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $50,088 10 payments
  2. Food and Beverage $7,322 87 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,750 2 payments
  4. Travel and Lodging $4,389 16 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $1,500 1 payment
Products named General payments · program years 2021–2025
  1. ACTIS $15,681 28 payments
  2. ATTUNE $12,800 8 payments
  3. Velys $12,504 4 payments
  4. PREVENA RESTOR ARTHROFORM $11,959 8 payments
  5. PREVENA RESTOR AXIOFORM $11,759 6 payments
  6. PREVENA $11,297 4 payments
  7. V.A.C. VERAFLO $10,458 4 payments
  8. AQUAMANTYS(TM) $4,750 2 payments
  9. PREVENA RESTOR ROTOFORM $850 1 payment
  10. PREVENA RESTOR BELLAFORM $850 1 payment
  11. Other $5,248 63 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2021–2025
  1. PolarisAR Inc $3,350 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

431

Median for Orthopedic Surgery: 203

Drug cost

$2,524

Median for Orthopedic Surgery: $1,433

Branded share of claims

3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 354 $933
Diclofenac Sodium Er Diclofenac Sodium Brand 13 $875
Celecoxib Generic 40 $640
Oxycodone Hcl Generic 11 $43
Tramadol Hcl Generic 13 $34

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$137,316

Of which drugs: $9,179

Medicare patients

451

Average age 77

Services billed

3,575

287 women, 164 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 73%
Diabetes 30%
Ischemic heart disease 28%
Cancer 21%
Osteoporosis 20%
Depression 19%
COPD 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose J7326 Office 16 22 $8,888
Injection, methylprednisolone acetate, 1 mg J1010 Office 26 2,480 $251

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

117 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record